Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops
Yu Guo, Andrew Perez, Dennis J. Hazelett, et al.
Genome biology (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

CRISPR technologies for precise epigenome editing
Muneaki Nakamura, Yuchen Gao, Antonia A. Dominguez, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 1, pp. 11-22
Closed Access | Times Cited: 353
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
Joanna Achinger-Kawecka, Fátima Valdés‐Mora, Phuc‐Loi Luu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 143
Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements
Josh Tycko, Michael Wainberg, Georgi K. Marinov, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 128
A high-resolution 3D epigenomic map reveals insights into the creation of the prostate cancer transcriptome
Suhn K. Rhie, Andrew Perez, Fides D. Lay, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 116
Regulatory SNPs: Altered Transcription Factor Binding Sites Implicated in Complex Traits and Diseases
A. O. Degtyareva, E. V. Antontseva, Т. И. Меркулова
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6454-6454
Open Access | Times Cited: 56
Engineering 3D genome organization
Haifeng Wang, Mengting Han, Lei S. Qi
Nature Reviews Genetics (2021) Vol. 22, Iss. 6, pp. 343-360
Closed Access | Times Cited: 51
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer
Musaddeque Ahmed, Fraser Soares, Ji‐Han Xia, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 45
MYC reshapes CTCF-mediated chromatin architecture in prostate cancer
Wei Zhao, Song Wang, Yaning Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Gene-Specific Actions of Transcriptional Coregulators Facilitate Physiological Plasticity: Evidence for a Physiological Coregulator Code
Michael R. Stallcup, Coralie Poulard
Trends in Biochemical Sciences (2020) Vol. 45, Iss. 6, pp. 497-510
Open Access | Times Cited: 49
Loop competition and extrusion model predicts CTCF interaction specificity
Xi Wang, M Beer
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 40
Spatial promoter–enhancer hubs in cancer: organization, regulation, and function
Jingru Zhao, Robert B. Faryabi
Trends in cancer (2023) Vol. 9, Iss. 12, pp. 1069-1084
Open Access | Times Cited: 14
The interplay of chromatin and transcription factors during cell fate transitions in development and reprogramming
Georgina Peñalosa-Ruiz, Ann Rose Bright, Klaas W. Mulder, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2019) Vol. 1862, Iss. 9, pp. 194407-194407
Open Access | Times Cited: 38
Chromosome compartmentalization alterations in prostate cancer cell lines model disease progression
Rebeca San Martin, Priyojit Das, Renata Dos Reis Marques, et al.
The Journal of Cell Biology (2021) Vol. 221, Iss. 2
Open Access | Times Cited: 30
The 3D Genome as a Target for Anticancer Therapy
Omar L. Kantidze, Katerina V. Gurova, Vasily M. Studitsky, et al.
Trends in Molecular Medicine (2019) Vol. 26, Iss. 2, pp. 141-149
Open Access | Times Cited: 30
CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis
Qiuhua Lai, Qingyuan Li, Chengcheng He, et al.
Aging (2020) Vol. 12, Iss. 16, pp. 16270-16293
Open Access | Times Cited: 28
CCCTC-binding factor regulates splicing factor proline and glutamine-rich to promote malignant growth of osteosarcoma
Dapeng Li, Yang Yang, Zhengyu Yin, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1495-1509
Closed Access
Editing the CYP19 Gene in Goat Embryos Using CRISPR/Cas9 and Somatic Cell Nuclear Transfer Techniques
Ahmad Pirali, Farnoosh Jafarpour, Mehdi Hajian, et al.
Cellular Reprogramming (2025)
Closed Access
RobusTAD: reference panel based annotation of nested topologically associating domains
Yanlin Zhang, Rola Dali, Mathieu Blanchette
Genome biology (2025) Vol. 26, Iss. 1
Open Access
Target-enriched nanopore sequencing and de novo assembly reveals co-occurrences of complex on-target genomic rearrangements induced by CRISPR-Cas9 in human cells
Keyi Geng, Lara G. Merino, Linda Wedemann, et al.
Genome Research (2022)
Open Access | Times Cited: 16
RPL35A drives ovarian cancer progression by promoting the binding of YY1 to CTCF promoter
Huijuan Wu, Liangbin Xia, Lu Sun, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 3
Dysregulated Transcriptional Control in Prostate Cancer
Simon J. Baumgart, Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 2883-2883
Open Access | Times Cited: 25
Nuclear Receptor Coregulators in Hormone-Dependent Cancers
Hedieh Jafari, Shahid Hussain, Moray J. Campbell
Cancers (2022) Vol. 14, Iss. 10, pp. 2402-2402
Open Access | Times Cited: 14
CRISPR/Cas9-mediated targeted knock-in of large constructs using nocodazole and RNase HII
Shahin Eghbalsaied, Wilfried A. Kues
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Chromatin reprogramming as an adaptation mechanism in advanced prostate cancer
Peder R. Braadland, Alfonso Urbanucci
Endocrine Related Cancer (2019) Vol. 26, Iss. 4, pp. R211-R235
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top